A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
Public ClinicalTrials.gov record NCT06809179. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Three-arm, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol (PH94B) Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension
Study identification
- NCT ID
- NCT06809179
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- VistaGen Therapeutics, Inc.
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Fasedienol Nasal Spray - Fasedienol Nasal Spray Drug
- Fasedienol Nasal Spray - Placebo Nasal Spray Drug
- Placebo Nasal Spray - Placebo Nasal Spray Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 8, 2025
- Primary completion
- Mar 31, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Feb 4, 2026
2025 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vistagen Clinical Site | Sherman Oaks | California | 91403 | Recruiting |
| Vistagen Clinical Site | Walnut Creek | California | 94596 | Recruiting |
| Vistagen Clinical Site | Largo | Florida | 33777 | Recruiting |
| Vistagen Clinical Site | Saint Charles | Missouri | 63304 | Recruiting |
| Vistagen Clinical Site | Toms River | New Jersey | 08755 | Recruiting |
| Vistagen Clinical Site | Cary | North Carolina | 27511 | Recruiting |
| Vistagen Clinical Site | Cleveland | Ohio | 44130 | Terminated |
| Vistagen Clinical Site | Plymouth Meeting | Pennsylvania | 19462 | Recruiting |
| Vistagen Clinical Site | Plano | Texas | 75093 | Terminated |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06809179, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06809179 live on ClinicalTrials.gov.